Retroscreen Virology is Europe’s leading specialist virology contract research organisation. The company provides high value preclinical and clinical research services to the pharmaceutical and biotech industries, helping to develop the next generation of anitiviral drugs and vaccines for respiratory and enteric diseases, with a particular focus on influenza.

The company has experienced strong growth over recent years based on a track record of scientific expertise and commercial delivery in an increasingly important area of medicine.